Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-02-19

Clinical Trial Update: Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating intradermal Avotermin (RN1001) for skin scarring in elderly subjects; results completed with safety and efficacy updates.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avotermin (Avotermin)

Snippet

Sponsor: Renovo | Conditions: Cicatrix | Phase 1, Phase 2 | Status: COMPLETED